Open AccessDREADD Agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo
Author(s) -
K.J. Thompson,
E. Khajehali,
S.J. Bradley,
J.S. Navarrete,
X.P. Huang,
S.T Slocum,
J. Jin,
J. Liu,
Yiting Xiong,
R.H.J. Olsen,
J.F. Diberto,
K.M. Boyt,
M.M. Pina,
D. Pati,
C. Molloy,
C. Bundgaard,
P.M. Sexton,
T.L. Kash,
M.J. Krashes,
A. Christopoulos,
B.L. Roth,
A.B. Tobin
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/g3y2-9z91
Subject(s) - agonist , in vivo , muscarinic agonist , muscarinic acetylcholine receptor , pharmacology , neuroscience , in vitro , chemistry , medicine , receptor , psychology , biology , biochemistry , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom